Interaction Studies of Tipranavir-Ritonavir with Clarithromycin, Fluconazole, and Rifabutin in Healthy Volunteers

Three separate controlled, two-period studies with healthy volunteers assessed the pharmacokinetic interactions between tipranavir-ritonavir (TPV/r) in a 500/200-mg dose and 500 mg of clarithromycin (CLR), 100 mg of fluconazole (FCZ), or 150 mg of rifabutin (RFB). The CLR study was conducted with 24...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: la Porte, Charles J. L., Sabo, John P., Elgadi, Mabrouk, Cameron, D. William
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2009
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2612183/
https://ncbi.nlm.nih.gov/pubmed/19015362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00534-08
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares